Ilaria Viozzi1, Alis Guberinic1, Christiaan G Overduin2, Maroeska M Rovers3, Mark Ter Laan1. 1. Department of Neurosurgery, Radboud University Medical Center, Radboud Institute for Health Sciences, 6525 GA Nijmegen, The Netherlands. 2. Department of Radiology, Radboud University Medical Center, Radboud Institute for Health Sciences, 6525 GA Nijmegen, The Netherlands. 3. Departments of Health Evidence and Operating Rooms, Radboud University Medical Center, Radboud Institute for Health Sciences, 6525 GA Nijmegen, The Netherlands.
Abstract
BACKGROUND: Laser interstitial thermal therapy (LITT) is a minimal invasive neurosurgical technique for the treatment of brain tumors. Results of LITT have been reported in a case series of patients with deep seated and/or recurrent glioblastoma or cerebral metastases. With this review we aim to summarize the currently available evidence regarding safety and effectiveness of LITT in patients with newly diagnosed glioblastoma (nGBM). METHODS: A literature search was performed using electronic databases (PubMed and Embase). Papers were assessed for the methodological quality using the Risk Of Bias In Non- randomised Studies - of Interventions (ROBINS-I) tool, and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) was used to assess the quality of the evidence. RESULTS: We identified 835 papers of which only 11 articles were eligible for our review. All papers suffered from serious or critical risk of bias, and the quality of evidence was graded as very low according to the GRADE criteria. None of the studies was randomized and reporting of confounders and other parameters was poor. Median overall survival (OS) ranged from 4.1 to 32 months and progression free survival (PFS) from 2 to 31 months. The mean complication rate was 33.7%. No quality of life or cost-effectiveness data were reported. CONCLUSIONS: Due to the low quality of the studies, it is not possible to draw firm conclusions regarding the (cost) effectiveness of LITT in patients with newly diagnosed glioblastoma. The low quality of evidence shows the need for a well-designed prospective multicenter randomized controlled trial.
BACKGROUND: Laser interstitial thermal therapy (LITT) is a minimal invasive neurosurgical technique for the treatment of brain tumors. Results of LITT have been reported in a case series of patients with deep seated and/or recurrent glioblastoma or cerebral metastases. With this review we aim to summarize the currently available evidence regarding safety and effectiveness of LITT in patients with newly diagnosed glioblastoma (nGBM). METHODS: A literature search was performed using electronic databases (PubMed and Embase). Papers were assessed for the methodological quality using the Risk Of Bias In Non- randomised Studies - of Interventions (ROBINS-I) tool, and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) was used to assess the quality of the evidence. RESULTS: We identified 835 papers of which only 11 articles were eligible for our review. All papers suffered from serious or critical risk of bias, and the quality of evidence was graded as very low according to the GRADE criteria. None of the studies was randomized and reporting of confounders and other parameters was poor. Median overall survival (OS) ranged from 4.1 to 32 months and progression free survival (PFS) from 2 to 31 months. The mean complication rate was 33.7%. No quality of life or cost-effectiveness data were reported. CONCLUSIONS: Due to the low quality of the studies, it is not possible to draw firm conclusions regarding the (cost) effectiveness of LITT in patients with newly diagnosed glioblastoma. The low quality of evidence shows the need for a well-designed prospective multicenter randomized controlled trial.
Authors: Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher Journal: J Clin Epidemiol Date: 2009-07-23 Impact factor: 6.437
Authors: Joon Y Kang; Chengyuan Wu; Joseph Tracy; Matthew Lorenzo; James Evans; Maromi Nei; Christopher Skidmore; Scott Mintzer; Ashwini D Sharan; Michael R Sperling Journal: Epilepsia Date: 2015-12-24 Impact factor: 5.864
Authors: Robert T Wicks; Walter J Jermakowicz; Jonathan R Jagid; Daniel E Couture; Jon T Willie; Adrian W Laxton; Robert E Gross Journal: Neurosurgery Date: 2016-12 Impact factor: 4.654
Authors: Ashwin A Kamath; Daniel D Friedman; Carl D Hacker; Matthew D Smyth; David D Limbrick; Albert H Kim; Ammar H Hawasli; Eric C Leuthardt Journal: Stereotact Funct Neurosurg Date: 2018-01-17 Impact factor: 1.875
Authors: Alireza M Mohammadi; Mayur Sharma; Thomas L Beaumont; Kevin O Juarez; Hanna Kemeny; Cosette Dechant; Andreas Seas; Nehaw Sarmey; Bryan S Lee; Xuefei Jia; Peter E Fecci; Joachim Baehring; Jennifer Moliterno; Veronica L Chiang; Manmeet S Ahluwalia; Albert H Kim; Gene H Barnett; Eric C Leuthardt Journal: Neurosurgery Date: 2019-12-01 Impact factor: 5.315
Authors: Ashwin A Kamath; Daniel D Friedman; S Hassan A Akbari; Albert H Kim; Yu Tao; Jinqin Luo; Eric C Leuthardt Journal: Neurosurgery Date: 2019-04-01 Impact factor: 4.654
Authors: Philip C De Witt Hamer; Vincent K Y Ho; Aeilko H Zwinderman; Linda Ackermans; Hilko Ardon; Sytske Boomstra; Wim Bouwknegt; Wimar A van den Brink; Clemens M Dirven; Niels A van der Gaag; Olivier van der Veer; Albert J S Idema; Alfred Kloet; Jan Koopmans; Mark Ter Laan; Marco J T Verstegen; Michiel Wagemakers; Pierre A J T Robe Journal: J Neurooncol Date: 2019-06-24 Impact factor: 4.130
Authors: Alireza M Mohammadi; Ammar H Hawasli; Analiz Rodriguez; Jason L Schroeder; Adrian W Laxton; Paul Elson; Stephen B Tatter; Gene H Barnett; Eric C Leuthardt Journal: Cancer Med Date: 2014-05-09 Impact factor: 4.452